Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Asthma. 2017 Jul 13;55(4):364–372. doi: 10.1080/02770903.2017.1339245

Table 1.

Characteristics of ever-employed adults with current asthma by history of medication use in the last 3 months.

No. in Samplea Weighted
Medication use in last 3 months
%b (95% CI)
No medication use in last 3 months
%b (95% CI)
No.a %b (95% CI)
Total 14 915 15 120 762 100.0 100.0
Agec
 18–44 3099 6 841 498 45.4 (43.4–47.4) 40.4 (37.9–42.8) 54.7 (51.4–58.1)
 45–64 6824 5 591 020 37.1 (35.4–38.8) 39.5 (37.3–41.6) 32.8 (29.8–35.7)
 ≥65 4929 2 634 581 17.5 (16.4–18.6) 20.2 (18.7–21.6) 12.5 (11.0–14.0)
Sexc
 Male 4307 5 206 981 34.4. (32.6–36.3) 32.7 (30.5–34.8) 37.7 (34.3–41.2)
 Female 10 608 9 913 780 65.6 (63.7–67.4) 67.3 (65.2–69.5) 62.3 (58.8–65.7)
Race/ethnicity
 Non-Hispanic, white 11 794 10 517 631 70.5 (68.6–72.5) 71.0 (68.5–73.4) 69.8 (66.3–73.3)
 Non-Hispanic, black 1124 1 840 601 12.3 (10.9–13.8) 12.8 (11.0–14.5) 11.6 (9.2–14.0)
 Hispanic 695 1 547 548 10.4 (8.9–11.9) 9.1 (7.3–10.9) 12.7 (9.9–15.6)
 Other 1108 1 005 121 6.7 (5.6–7.9) 7.2 (5.6–8.7) 5.9 (4.2–7.7)
Education
 ≤High school 5356 5 558 676 36.8 (34.9–38.7) 37.2 (35.0–39.5) 36.0 (32.7–39.3)
 Some college 4540 5 607 025 37.1 (35.2–39.1) 36.4 (34.1–38.7) 38.5 (34.9–42.0)
 College graduate 5003 3 942 694 26. 1 (24.6–27.6) 26.4 (24.6–28.2) 25.6 (22.8–28.4)
Household income
 <$15,000 2586 2 299 211 17.1 (15.6–18.6) 18.0 (16.2–19.8) 15.4 (12.7–18.1)
 $15,000–$24,999 2779 2 470 877 18.4 (16.9–19.9) 17.7 (15.9–19.5) 19.6 (17.0–22.2)
 $25,000–$34,999 1482 1 363 071 10.1 (8.9–11.4) 10.3 (8.9–11.6) 9.9 (7.5–12.3)
 $35,000–$49,999 1757 1 654 115 12.3 (11.1–13.5) 12.3 (10.8–13.7) 12.3 (10.1–14.5)
 ≥$50,000 4834 5 664 151 42.1 (40.1–44.1) 41.7 (39.4–44.1) 42.8 (39.2–46.4)
Health insurancec
 Yes 13 493 13 069 439 86.6 (85.2–88.0) 88.3 (86.6–90.0) 83.6 (81.1–86.1)
 No 1390 2 016 308 13.4 (12.0–14.8) 11.7 (10.0–13.4) 16.4 (13.9–18.9)
Smoking statusc
 Current 2568 3 017 332 20.0 (18.4–21.6) 20.7 (18.8–22.6) 18.7 (15.8–21.6)
 Former 5068 4 152 733 27.5 (25.9–29.1) 30.4 (28.4–32.4) 22.2 (19.6–24.8)
 Never 7237 7 910 921 52.5 (50.5–54.4) 48.9 (46.6–51.2) 59.1 (55.7–62.5)
Asthma status
 WRA 2338 2 224 263 14.7 (13.4–16.0) 15.8 (14.1–17.4) 12.8 (10.6–15.0)
 Possible WRA 6209 6 094 064 40.4 (38.5–42.2) 41.8 (39.6–44.1) 37.6 (34.2–40.9)
 Non-WRA 6338 6 784 072 44.9 (43.0–46.9) 42.4 (40.1–44.7) 49.6 (46.1–53.1)
Asthma control
 Well controlled 6743 7 554 008 50.0 (48.0–51.9) 47.4 (36.1–58.6) 96.3 (95.0–97.5)
 Not well controlled 3959 3 855 751 25.5 (23.9–27.1) 21.0 (11.6–30.4) 3.0 (1.8–4.1)
 Very poorly controlled 4210 3 710 704 24.5 (23.0–26.1) 31.6 (20.8–42.4)
Adverse asthma outcomes
 Asthma attack in past 12 monthsc 7705 7 807 696 51.9 (50.0–53.9) 60.6 (58.3–62.8) 35.9 (32.7–39.1)
 Urgent treatment for worsening asthmac 3528 3 466 275 43.5 (40.9–46.1) 64.0 (60.6–67.4) 17.4 (14.3–20.5)
 Asthma-related emergency room visitc 1845 2 041 792 13.5 (12.2–14.9) 17.7 (15.8–19.6) 5.8 (4.3–7.3)
 Overnight stay in hospital because of asthmac 555 549 438 3.6 (2.9–4.4) 4.8 (3.8–5.8) 1.5 (0.7–2.4)
a

Categories do not sum to total due to item non-response.

b

Results presented as weighted annual average.

c

Rao–Scott chi-square test p < 0.05.